Aadi Bioscience Statistics Share Statistics Aadi Bioscience has 46.29M
shares outstanding. The number of shares has increased by 88.05%
in one year.
Shares Outstanding 46.29M Shares Change (YoY) 88.05% Shares Change (QoQ) 0% Owned by Institutions (%) 74.99% Shares Floating 8.31M Failed to Deliver (FTD) Shares 10 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 965.83K, so 0% of the outstanding
shares have been sold short.
Short Interest 965.83K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 3.1
Valuation Ratios The PE ratio is -1.34 and the forward
PE ratio is -2.16.
Aadi Bioscience's PEG ratio is
0.41.
PE Ratio -1.34 Forward PE -2.16 PS Ratio 3.28 Forward PS 6.3 PB Ratio 1.63 P/FCF Ratio -1.39 PEG Ratio 0.41
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aadi Bioscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.59,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.59 Quick Ratio 3.28 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -438.04
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $490.25K Profits Per Employee $-1.2M Employee Count 53 Asset Turnover 0.37 Inventory Turnover 0.57
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 29.75% in the
last 52 weeks. The beta is 0.34, so Aadi Bioscience's
price volatility has been higher than the market average.
Beta 0.34 52-Week Price Change 29.75% 50-Day Moving Average 2.21 200-Day Moving Average 2.12 Relative Strength Index (RSI) 37.54 Average Volume (20 Days) 200,709
Income Statement In the last 12 months, Aadi Bioscience had revenue of 25.98M
and earned -63.69M
in profits. Earnings per share was -2.36.
Revenue 25.98M Gross Profit 22.96M Operating Income -67.46M Net Income -63.69M EBITDA -64.63M EBIT -64.82M Earnings Per Share (EPS) -2.36
Full Income Statement Balance Sheet The company has 28.67M in cash and 833K in
debt, giving a net cash position of 27.84M.
Cash & Cash Equivalents 28.67M Total Debt 833K Net Cash 27.84M Retained Earnings -332.65M Total Assets 180.82M Working Capital 169.91M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.55M
and capital expenditures -1.65M, giving a free cash flow of -61.2M.
Operating Cash Flow -59.55M Capital Expenditures -1.65M Free Cash Flow -61.2M FCF Per Share -2.27
Full Cash Flow Statement Margins Gross margin is 88.36%, with operating and profit margins of -259.62% and -245.13%.
Gross Margin 88.36% Operating Margin -259.62% Pretax Margin -245.13% Profit Margin -245.13% EBITDA Margin -248.72% EBIT Margin -259.62% FCF Margin -235.55%
Dividends & Yields AADI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AADI is $1.75,
which is -14.6% lower than the current price. The consensus rating is "Hold".
Price Target $1.75 Price Target Difference -14.6% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 27, 2021. It was a
backward
split with a ratio of 1:15.
Last Split Date Aug 27, 2021 Split Type backward Split Ratio 1:15
Scores Altman Z-Score 5.09 Piotroski F-Score 2
